文献速递胸部CTUS

不同疾病流行率人群中入院胸部CT与肺超声诊断COVID-19肺炎的性能比较

Comparison of admission chest computed tomography and lung ultrasound performance for diagnosis of COVID-19 pneumonia in populations with different disease prevalence.
PubMed 文献 · Eur J Radiol · 2020-10-08

研究纳入2020年2月21日至3月6日(高流行组,HP)及3月30日至4月13日(中流行组,MP)急诊入院、12小时内完成肺超声和胸部CT的患者486例。以RT-PCR和血清学为参考标准,HP组COVID-19流行率94%、MP组45%;CT在HP组和MP组的AUC分别为0.75和0.85,均优于肺超声的0.51和0.62(P<0.001)。结论:入院胸部CT诊断COVID-19性能优于肺超声,肺超声敏感性高但特异性低。

要点

  • 胸部CT诊断COVID-19的AUC在高流行组为0.75、中流行组为0.85,均优于肺超声。
  • 肺超声敏感性高(高流行组94%、中流行组93%),但特异性低(7%–31%)。
  • COVID-19流行率变化时,CT诊断性能均优于肺超声。

核心结论

  • 入院胸部CT在不同疾病流行率下诊断COVID-19的性能均优于肺超声。
  • 肺超声对COVID-19敏感性高,但特异性低。

研究设计与样本

  • 研究纳入2020年2月21日至3月6日(高流行组)和3月30日至4月13日(中流行组)急诊入院、12小时内完成肺超声和胸部CT的患者486例(男性61%,中位年龄70岁)。
  • 高流行组247例,COVID-19流行率94%;中流行组239例,COVID-19流行率45%。
  • 以实时逆转录聚合酶链反应(RT-PCR)和血清学为参考标准,计算CT和肺超声的敏感度、特异度、PPV、NPV和AUC。

诊断标准与关键数值

  • 胸部CT采用RSNA分类系统,表现为「不确定」或「典型」模式判为阳性。
  • 肺超声在12个探查区中至少一个区域出现胸膜线增厚伴≥3条B线判为阳性。
  • 高流行组CT敏感度90%、特异度43%、PPV 96%、NPV 20%,AUC 0.75;中流行组CT敏感度95%、特异度69%、PPV 72%、NPV 95%,AUC 0.85。
  • 高流行组肺超声敏感度94%、特异度7%、PPV 94%、NPV 7%,AUC 0.51;中流行组肺超声敏感度93%、特异度31%、PPV 52%、NPV 83%,AUC 0.62。
  • CT诊断COVID-19的AUC在高流行组为0.75 vs 肺超声0.51(P<0.001),中流行组为0.85 vs 0.62(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Chest computed tomography (CT) is considered a reliable imaging tool for COVID-19 pneumonia diagnosis, while lung ultrasound (LUS) has emerged as a potential alternative to characterize lung involvement. The aim of the study was to compare diagnostic performance of admission chest CT and LUS for the diagnosis of COVID-19.

METHODS: We included patients admitted to emergency department between February 21-March 6, 2020 (high prevalence group, HP) and between March 30-April 13, 2020 (moderate prevalence group, MP) undergoing LUS and chest CT within 12 h. Chest CT was considered positive in case of "indeterminate"/"typical" pattern for COVID-19 by RSNA classification system. At LUS, thickened pleural line with ≥ three B-lines at least in one zone of the 12 explored was considered positive. Sensitivity, specificity, PPV, NPV, and AUC were calculated for CT and LUS against real-time reverse transcriptase polymerase chain reaction (RT-PCR) and serology as reference standard.

RESULTS: The study included 486 patients (males 61 %; median age, 70 years): 247 patients in HP (COVID-19 prevalence 94 %) and 239 patients in MP (COVID-19 prevalence 45 %). In HP and MP respectively, sensitivity, specificity, PPV, and NPV were 90-95 %, 43-69 %, 96-72 %, 20-95 % for CT and 94-93 %, 7-31 %, 94-52 %, 7-83 % for LUS. CT demonstrated better performance than LUS in diagnosis of COVID-19, both in HP (AUC 0.75 vs 0.51; P < 0.001) and MP (AUC 0.85 vs 0.62; P < 0.001).

CONCLUSIONS: Admission chest CT shows better performance than LUS for COVID-19 diagnosis, at varying disease prevalence. LUS is highly sensitive, but not specific for COVID-19.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Colombi D, Petrini M, Maffi G, et al. Comparison of admission chest computed tomography and lung ultrasound performance for diagnosis of COVID-19 pneumonia in populations with different disease prevalence. Eur J Radiol. 2020. PMID: 33091835. doi:10.1016/j.ejrad.2020.109344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。